New Label-Free Biosensing for the Evaluation of the AX-024 Inhibitor: Case Study for the Development of New Drugs in Autoimmune Diseases
We developed a new label-free assay to evaluate the inhibition capacity of AX-024 by means of a new Point-of-Care (PoC) device for application in the development of new drugs in autoimmune diseases. The technology of PoC is based on interferometric optical detection method (IODM). For this purpose,...
Main Authors: | Yolanda Ramírez, María Fe Laguna, Miguel Holgado |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Sensors |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8220/22/3/1218 |
Similar Items
-
A Point-of-Care Based on Label-Free Interferometric Optical Detection Method to Evaluate Interferon Gamma (IFN-γ): A Correlation with the ELISA Technique
by: María Fe Laguna Heras, et al.
Published: (2020-08-01) -
A Fiber Bragg Grating Sensor Based on Cladding Mode Resonance for Label-Free Biosensing
by: Shimeng Chen, et al.
Published: (2023-01-01) -
On the Determination of Uncertainty and Limit of Detection in Label-Free Biosensors
by: Álvaro Lavín, et al.
Published: (2018-06-01) -
Efficient Chemical Surface Modification Protocol on SiO<sub>2</sub> Transducers Applied to MMP9 Biosensing
by: Ana L. Hernandez, et al.
Published: (2021-12-01) -
ZnO Tetrapods for Label-Free Optical Biosensing: Physicochemical Characterization and Functionalization Strategies
by: Monica Terracciano, et al.
Published: (2023-02-01)